You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.

 

IC-ONC
Immunotherapy Collaborative of Oncology Networked Communities

Immunotherapy Collaborative of Networked Communities (IC ONC) is an initiative designed to educate oncologists and the cancer team on advances in cancer immunotherapy.

IC-ONC collaborators include the following professional societies,
educational providers and outcomes partners:

Med Learning Group

In partnership with

American Society for Clinical Pathology (ASCP)

Supported by an educational grant from

Bristol-Myers Squibb

IC-ONC collaborators include the following professional societies,
educational providers and outcomes partners:

Medscape Education Oncology

In partnership with

Association of Community Cancer Centers

Supported by an educational grant from

Bristol-Myers Squibb

IC-ONC collaborators include the following professional societies,
educational providers and outcomes partners:

The Micron Group

In partnership with

American Society for Clinical Pathology (ASCP)

Supported by an educational grant from

Bristol-Myers Squibb

IC-ONC collaborators include the following professional societies,
educational providers and outcomes partners:

National Comprehensive Cancer Network (NCCN)

In partnership with

Association of Community Cancer Centers

Supported by an educational grant from

Bristol-Myers Squibb

IC-ONC collaborators include the following professional societies,
educational providers and outcomes partners:

TOPEC Global

In partnership with

American Society for Clinical Pathology (ASCP)

Supported by an educational grant from

Bristol-Myers Squibb

IC-ONC collaborators include the following professional societies,
educational providers and outcomes partners:

Med Learning Group

In partnership with

Association of Community Cancer Centers

Supported by an educational grant from

Bristol-Myers Squibb

IC-ONC collaborators include the following professional societies,
educational providers and outcomes partners:

Medscape Education Oncology

In partnership with

American Society for Clinical Pathology (ASCP)

Supported by an educational grant from

Bristol-Myers Squibb

IC-ONC collaborators include the following professional societies,
educational providers and outcomes partners:

The Micron Group

In partnership with

Association of Community Cancer Centers

Supported by an educational grant from

Bristol-Myers Squibb

IC-ONC collaborators include the following professional societies,
educational providers and outcomes partners:

National Comprehensive Cancer Network (NCCN)

In partnership with

American Society for Clinical Pathology (ASCP)

Supported by an educational grant from

Bristol-Myers Squibb

IC-ONC collaborators include the following professional societies,
educational providers and outcomes partners:

TOPEC Global

In partnership with

Association of Community Cancer Centers

Supported by an educational grant from

Bristol-Myers Squibb

About Us

IC Onc Logo


IC-ONC has been designed to build local communities that serve as the foundation of a global network in which multidisciplinary clinicians responsible for treating patients with cancer are connected via education. Resources curated by both national and local oncology experts are made available to facilitate ongoing communication and collaboration among participating clinicians with the aim of providing optimal care for the patient.

Find Your Network Community

Resources

Downloadable Slide Kit

A 3D Tour of Immuno-Oncology - From Los Angeles

Experts Adil Daud, MD, Jose Lutzky, MD, and Peter Schmid, MD, PhD, FRCP. Recent trials in immunotherapy have changed the approach to treatment of solid tumors.

Download

A 3D Tour of Immuno-Oncology - From Chicago

Experts Arjun V. Balar, MD, Jason Luke, MD, FACP, and Jeffrey S. Weber, MD, PhD. Recent trials in immunotherapy have changed the approach to treatment of solid tumors.

Download

A 3D Tour of Immuno-Oncology - From Miami

Experts Adil Daud, MD, Jose Lutzky, MD, and Peter Schmid, MD, PhD, FRCP. Recent trials in immunotherapy have changed the approach to treatment of solid tumors.

Download

A 3D Tour of Immuno-Oncology - From London, UK

Experts Farah Louise Lim, MD and Peter Schmid, MD, PhD, FRCP. Recent trials in immunotherapy have changed the approach to treatment of solid tumors.

Download

Immunotherapy and Head and Neck Squamous Cell Carcinoma

Review the latest insights into the use of immunotherapy in squamous cell head and neck cancer.

Download

Animations

Animation 1: Cancer and the Immune System

Animation 2: Immune Checkpoint Blockade: PD-1_PD-L1_CIT_PD1

Ask the Experts

What are your questions and comments on the use of immune checkpoint inhibition in the treatment of cancer?

Join the Discussion

Polling Question

IC-ONC Observatory Logo

Coming Soon

As part of our multi-year project we will perform some innovative observational outcomes studies, looking at the impact of our educational programs and community participation in improving patient outcomes.

If you would like to participate in our Observatory, please send an email to [email protected] to request additional information or to be enrolled in this exciting project.

Scientific Advisory Council Chair and Members

Jeffrey S. Weber, MD, PhD

Laura and Isaac Perlmutter Professor of Oncology, Department of Medicine, NYU Langone Medical Center, New York, NY

Arjun Balar, MD

Assistant Professor of Medicine; Director-Genitourinary Medical Oncology Program, NYU Perlmutter Cancer Center, NYU Langone Medical Center, New York, NY

Padmanee Sharma, MD, PhD

Professor, Department of Genitourinary Medical Oncology; Professor, Department of Immunology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

Professor Peter Schmid, FRCP, MD, PhD

Centre Lead, Centre for Experimental Cancer Medicine, Director, Breast Cancer, St Bartholomew Hospital, London, UK

Vamsidhar Velcheti, MD

Department of Hematology and Oncology, Associate Director, Center for Immuno-Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio

Community Event Speakers

Adil Daud, MD

HS Clinical Professor, Department of Medicine (Hematology/Oncology); USCF Director, Melanoma Clinical Research, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA

Edward B. Garon, MD

Associate Professor, David Geffen School of Medicine at UCLA, Los Angeles, CA

Jason Luke, MD, FACP

Assistant Professor of Medicine, The University of Chicago Medicine, Chicago, IL

Isabella Glitza, MD, PhD

Assistant Professor, Department of Melanoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

Kim Margolin, MD

Clinical Professor, Department of Medical Oncology & Therapeutics Research, City of Hope, Duarte, CA

Jose Lutzky, MD

Chief, Division of Hematology & Oncology; Chair, Cancer Research Committee; Director, Mount Sinai Melanoma Program, Miami Beach, FL

Dr. Farah Louise Lim, MBBS MRCP

Barts Cancer Institute Centre for Experimental Cancer Medicine, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, London